- Cabozantinib (XL184) and R428 (BGB324) Inhibit the Growth of Esophageal Squamous Cell Carcinoma (ESCC)
Pei-Wen Yang et al, 2019, Frontiers in Oncology CrossRef - AXL Inhibitors: Status of Clinical Development
Sheena Bhalla et al, 2023, Current Oncology Reports CrossRef - Immune escape and metastasis mechanisms in melanoma: breaking down the dichotomy
Carl A. Shirley et al, 2024, Frontiers in Immunology CrossRef - Curcumin: Modulator of Key Molecular Signaling Pathways in Hormone-Independent Breast Cancer
Reyhaneh Farghadani et al, 2021, Cancers CrossRef - Qigesan inhibits esophageal cancer cell invasion and migration by inhibiting Gas6/Axl-induced epithelial-mesenchymal transition
Lingyu Kong et al, 2020, Aging CrossRef